This long-lasting tumor immunity is likely mediated by an IL-10 signaling pathway specific for intratumoral CD8+ T cells, IL-10-induced STAT1 and STAT3 phosphorylation, and IFN-γ expression in intratumoral CD8+ T cells [52]. The gene discussed is CD8A; the disease is neoplasm.